• Home
  • Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer.

Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer.

Author List
Jackisch C, Barcenas CH, Bartsch R, Palma JD, Glück S, Harbeck N, Macedo G, O'Shaughnessy J, Pistilli B, Ruiz-Borrego M, Rugo HS
Publication
Clinical breast cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/182135546
Publication Year
2021
PubMed ID
33678567
Publication Title
Jackisch C, Barcenas CH, Bartsch R, Palma JD, Glück S, Harbeck N, Macedo G, O'Shaughnessy J, Pistilli B, Ruiz-Borrego M, Rugo HS. Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer. Clin Breast Cancer. 2021 10; 21(5):e575-e583.